REFLEXION PHARMACEUTICALS
Reflexion Pharmaceuticals is a biotechnology firm that develops protein-based therapeutics and D-peptides to create drugs.
REFLEXION PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
1902-01-01
Address:
Incline Village, Nevada, United States
Country:
United States
Website Url:
http://www.reflexionpharma.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud
Current Employees Featured
Official Site Inspections
http://www.reflexionpharma.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Reflexion Pharmaceuticals"
Home Page - RefleXion
SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated …See details»
Our Company - RefleXion
We’re bringing together medical physics, nuclear medicine and radiotherapy in new ways to shift the paradigm of cancer care. Our belief in the difference we can make knows no bounds. To …See details»
Reflexion Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
View Reflexion Pharmaceuticals (www.reflexionpharma.com) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
RefleXion Announces Initial Close of $105M …
Nov 15, 2023 · These new funds will allow RefleXion to extend commercialization of its breakthrough SCINTIX ® therapy for treating all stages of indicated solid tumor cancers, including metastatic disease.See details»
Reflexion Pharmaceuticals - Crunchbase Company …
Reflexion Pharmaceuticals is a biotechnology firm that develops protein-based therapeutics and D-peptides to create drugs. There is no recent news or activity for this profile. View contacts for Reflexion Pharmaceuticals to access new …See details»
RefleXion Announces Initial Close of $105M Fundraising to …
HAYWARD, Calif., November 15, 2023 -- (BUSINESS WIRE)-- RefleXion Medical, a therapeutic oncology company, today announced the initial closing of a $105M equity raise, led by The …See details»
Reflexion Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
May 1, 2024 · Explore Reflexion Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, .See details»
Reflexion Pharmaceuticals - VentureRadar
Website: https://www.reflexionpharma.com/ Develops revolutionary protein-based therapeutics, overcoming limitations of current biologics using enantiomeric D-peptides, improving …See details»
Nextsource | Company Profile | Reflexion Pharmaceuticals
Explore the company profile of Reflexion Pharmaceuticals (reflexionpharma.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
RefleXion Raises $100 Million for Cancer Treatment …
Apr 16, 2020 · RefleXion is a privately-held company developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment …See details»
Reflexion Pharmaceuticals - Berkeley Startup Cluster
Pioneering a mirror world of D-therapeutics invisible to enzymesSee details»
Leadership - RefleXion
Our leadership team embodies experts who know that our success rides on the shoulders of our team members and advisors. They are solely focused on creating a world-class team working …See details»
Tenant Spotlight: Reflexion Pharmaceuticals & The Mirror World …
Reflexion Pharma is pioneering a mirror world of D-therapeutics invisible to enzymes. L-R: CEO Greg Went, CSO Jack Nguyen, Lili Uchida, Sarah Chapman & Edward Chapman of Chapman …See details»
Reflexion Pharmaceuticals - Products, Competitors, Financials ...
Reflexion Pharmaceuticals is developing a novel process for making more effective protein therapeutics. You're one click away from the most comprehensive, unmatched analyst …See details»
RefleXion Announces Closing of $125M Debt Facility for …
Jul 6, 2022 · RefleXion is a privately-held company developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to …See details»
Press Releases - RefleXion
RefleXion Highlights New Cancer Treatment Research Abstracts for Prese... News and information about Reflexion medical. All you need to help develop your story.See details»
Reflexion pharmaceuticals - Biotech Careers
These new drug entities are non-immunogenic, resistant to proteolysis and present alternatives to antibody drugs. Reflexion Pharmaceuticals has used synthetic biology to develop a platform …See details»
RefleXion Acquires Global Rights to Radiopharmaceutical …
Sep 20, 2023 · RefleXion is a privately held therapeutic oncology company located in Hayward, Calif., commercializing SCINTIX biology-guided radiotherapy, a novel therapy that uses a …See details»
After Trump win, Black female political activists feel stung : NPR
3 days ago · After Kamala Harris lost the chance to become the first Black female president, many Black women political organizers say they are exhausted and taking a little break from politics.See details»
RefleXion Acquires Global Rights to Radiopharmaceutical …
Sep 20, 2023 · HAYWARD, Calif., and BERLIN, Sept. 20, 2023 – RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology …See details»